Heterologous prime boost vaccination with DNA and recombinant modified vaccinia virus Ankara protects IFNAR(-/-) mice against lethal bluetongue infection (Q39783365)

From Wikidata

Jump to navigation Jump to search

scientific article published on 24 October 2009

Language	Label	Description	Also known as
English	Heterologous prime boost vaccination with DNA and recombinant modified vaccinia virus Ankara protects IFNAR(-/-) mice against lethal bluetongue infection	scientific article published on 24 October 2009

Statements

scholarly article

1 reference

Europe PubMed Central

14 September 2017

Heterologous prime boost vaccination with DNA and recombinant modified vaccinia virus Ankara protects IFNAR(-/-) mice against lethal bluetongue infection (English)

1 reference

Europe PubMed Central

14 September 2017

bluetongue virus

0 references

object named as

vaccinia virus

1 reference

based on heuristic

inferred from title

author name string

Eva Calvo-Pinilla

1

1 reference

Europe PubMed Central

14 September 2017

Teresa Rodríguez-Calvo

2

1 reference

Europe PubMed Central

14 September 2017

Noemí Sevilla

3

1 reference

Europe PubMed Central

14 September 2017

Javier Ortego

4

1 reference

Europe PubMed Central

14 September 2017

language of work or name

0 references

publication date

24 October 2009

1 reference

Europe PubMed Central

14 September 2017

1 reference

Europe PubMed Central

14 September 2017

28

1 reference

Europe PubMed Central

14 September 2017

2

1 reference

Europe PubMed Central

14 September 2017

437-445

1 reference

Europe PubMed Central

14 September 2017

The epidemiology of bluetongue

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Bluetongue in northern Europe

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Assignment of the genome segments of bluetongue virus type 1 to the proteins which they encode.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Bluetongue virus entry into cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Genetic characterization of toggenburg orbivirus, a new bluetongue virus, from goats, Switzerland

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Analysis and phylogenetic comparisons of full-length VP2 genes of the 24 bluetongue virus serotypes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Changes in the outer capsid proteins of bluetongue virus serotype ten that abrogate neutralization by monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Bluetongue virus proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Prospects for improved bluetongue vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Antibody responses and protective immunity to recombinant vaccinia virus-expressed bluetongue virus antigens.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Expression of the major core structural protein (VP7) of bluetongue virus, by a recombinant capripox virus, provides partial protection of sheep against a virulent heterotypic bluetongue virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Recombinant capripoxviruses expressing proteins of bluetongue virus: evaluation of immune responses and protection in small ruminants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Role of neutralising antibody in passive immunity to bluetongue infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

The ovine cytotoxic T lymphocyte responses to bluetongue virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Antigen specificity of the ovine cytotoxic T lymphocyte response to bluetongue virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Enhancing DNA immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Efficacy of particle-based DNA delivery for vaccination of sheep against FMDV

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Priming with DNA plasmids encoding the nucleocapsid protein and glycoprotein precursors from Rift Valley fever virus accelerates the immune responses induced by an attenuated vaccine in sheep.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Protective immunity against porcine circovirus 2 in mice induced by a gene-based combination vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Heterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Prime-boost immunization with DNA followed by a recombinant vaccinia virus expressing P50 induced protective immunity against Babesia gibsoni infection in dogs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Establishment of a Bluetongue Virus Infection Model in Mice that Are Deficient in the Alpha/Beta Interferon Receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Functional role of type I and type II interferons in antiviral defense

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Bluetongue virus detection by two real-time RT-qPCRs targeting two different genomic segments.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Vaccines against bluetongue in Europe.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Bluetongue virus: virology, pathogenesis and immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

The non-structural proteins of bluetongue virus are a dominant source of cytotoxic T cell peptide determinants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

A DIVA system based on the detection of antibodies to non-structural protein 3 (NS3) of bluetongue virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Recombinant virus vaccine for bluetongue disease in sheep

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2009.10.027

1 reference

Europe PubMed Central

14 September 2017

1 reference

Europe PubMed Central

14 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39783365&oldid=2090324803"